Status:

UNKNOWN

A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study

Lead Sponsor:

McMaster University

Conditions:

Skin Cancer, Basal Cell

Skin Cancer

Eligibility:

All Genders

18+ years

Brief Summary

A prospective single-centered feasibility study will be conducted. The purpose of the feasibility study is to define the variables to be included in a subsequent pilot study, assess the feasibility of...

Detailed Description

A prospective single-centered feasibility study will be conducted. The purpose of the feasibility study is to define the variables to be included in a subsequent pilot study, assess the feasibility of...

Eligibility Criteria

Inclusion

  • Patients will be included in the study if:
  • they are 18 years or older
  • presenting for treatment of a suspected non-melanoma facial skin cancer, including pre-malignant cancers (i.e., actinic keratosis),
  • and scheduled to undergo reconstruction with either a skin graft or local tissue flap.

Exclusion

  • Patients will be excluded in the study if they:
  • present with altered level of consciousness,
  • cannot provide consent,
  • have facial nerve injury/previous facial nerve injury, have Melanoma skin cancer or Merkel cell carcinoma based on pathology reports, have polytrauma/multiple injuries, are pregnant, are undergoing free flap reconstruction, have bone involvement, or if they are under the age of 18.

Key Trial Info

Start Date :

April 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 1 2022

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04805905

Start Date

April 1 2021

End Date

February 1 2022

Last Update

March 18 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.